< Back to previous page
Patent
Means and methods for treatment of early-onset parkinson's disease
The present invention relates to the field of neurodegenerative diseases, more particularly to the field of Parkinson's disease. In particular the invention has found that inhibitors reducing FAS activity can be used for treatment of Parkinson's disease, in particular the treatment of patients suffering from Parkinson's disease having loss of function mutations in PINK1 or PARKIN genes.
Patent Publication Number: EP3220901
Year filing: 2020
Year approval: 2020
Year publication: 2020
Status: Assigned
URI: link to Espacenet
Technology domains: Pharmaceuticals
Validated for IOF-key: Yes
Attributed to: Associatie KULeuven